Immune-depleted tumor microenvironment is associated with poor outcomes and BTK inhibitor resistance in mantle cell lymphoma

Single nucleotide variants in immune-response genes and the tumor microenvironment composition predict progression of mantle cell lymphoma

(2021) Guilherme Rossi Assis-Mendonça et al.   BMC CANCER

Clinical and biological subtypes of B-cell lymphoma revealed by microenvironmental signatures

(2021) Nikita Kotlov et al.   Cancer Discovery

Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma

(2021) Shaojun Zhang et al.   Nature Communications

SOX11, CD70 and Treg cells configure the tumor immune microenvironment of aggressive mantle cell lymphoma

(2021) Patricia Balsas et al.   BLOOD

Conserved pan-cancer microenvironment subtypes predict response to immunotherapy

(2021) Alexander Bagaev et al.   CANCER CELL

Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition

(2019) Daisuke Ennishi et al.   Cancer Discovery

Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma

(2019) Liang Zhang et al.   Science Translational Medicine

New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded Biopsies

(2017) David W. Scott et al.   JOURNAL OF CLINICAL ONCOLOGY

Pathogenic role of B-cell receptor signaling and canonical NF-κB activation in mantle cell lymphoma

(2016) Nakhle S. Saba et al.   BLOOD

Postibrutinib outcomes in patients with mantle cell lymphoma

(2016) P. Martin et al.   BLOOD

Negative prognostic impact of low absolute CD4+T cell counts in peripheral blood in mantle cell lymphoma

(2016) Xin-Yu Zhang et al.   CANCER SCIENCE

T-Cell Levels Are Prognostic in Mantle Cell Lymphoma

(2014) L. Nygren et al.   CLINICAL CANCER RESEARCH